We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Brinton Pharmaceuticals announced that it has received USD 8 million from India Alternatives Investment Advisors. This transaction marks the second investment in Brinton by an institutional investor, following Tata Capital Healthcare Fund’s investment in